Total Voting Rights and Capital
In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:
The Company's issued share capital as at 30 September 2016 consisted of 5,367,261,326 Ordinary Shares of 25p each, of which 491,505,950 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is 4,875,755,376. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
V A Whyte
3 October 2016
This information is provided by RNS